Literature DB >> 283262

A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line.

S Pathak, M J Siciliano, R Cailleau, C L Wiseman, T C Hsu.   

Abstract

Pleural effusion was obtained from a 51-year-old black woman who had breast adenocarcinoma and had received chemotherapy and radiation therapy after a radical mastectomy. Cytogenetic and isoenzymic analyses of the cells were performed within a few hours of obtaining the sample. Similar analyses were also done with a cell line established from this effusion. The stemline chromosome number was 35, one of the lowest in human neoplasms. In addition to a marker chromosome involving 1q, which is common in human breast tumors, we found several other marker chromosomes whose G-banding patterns were similar to some of the typical HeLa markers. Genetic signature analysis of 15 isoenzyme loci revealed that 13 were identical to those of HeLa. Both HeLa and the cell line described here express glucose-6-phosphate dehydrogenase type a, yet they were derived from heterozygotic individuals (ab). Our data indicate the necessity to extensive cytogenetic and biochemical analysis before conclusions are made that cell lines are actually intercell-line contaminants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 283262

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

2.  Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.

Authors:  J Filmus; J G Church; R N Buick
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

4.  Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells.

Authors:  J G Church; G B Mills; R N Buick
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

Review 5.  Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.

Authors:  S Pathak
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

6.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.

Authors:  Delisha A Stewart; Jason H Winnike; Susan L McRitchie; Robert F Clark; Wimal W Pathmasiri; Susan J Sumner
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

8.  A molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic signatures.

Authors:  S J O'Brien; J E Shannon; M H Gail
Journal:  In Vitro       Date:  1980-02

Review 9.  Genetic predisposition to cancer with special reference to mutagen sensitivity.

Authors:  T C Hsu
Journal:  In Vitro Cell Dev Biol       Date:  1987-09

10.  Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants.

Authors:  J Filmus; J M Trent; M N Pollak; R N Buick
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.